Literature DB >> 449973

Serum ferritin as a possible marker of the hemochromatosis allele.

C Beaumont, M Simon, R Fauchet, J P Hespel, P Brissot, B Genetet, M Bourel.   

Abstract

To determine whether a correlation exists between the biochemical expression of hemochromatosis and the HLA genotype, we studied 174 family members of 32 persons with the disease. Persons who shared both HLA haplotypes with the proband (and presumably having two hemochromatosis alleles) differed significantly from those who shared only one haplotype (and presumably having one hemochromatosis allele) in terms of serum iron (P less than 0.001 for both sexes), unsaturated iron-binding capacity (P less than 0.01 for female and P less than 0.0001 for male subjects) and serum ferritin (P less than 0.0001 for female and P less than 0.00001 for male subjects). The only significant difference between relatives having one hemochromatosis allele and age and sex-matched controls was related to serum ferritin values in male subjects (P less than 0.05, despite considerable overlap). In our hands, serum ferritin was the best indicator of disordered iron metabolism and was elevated among most homozygous but among few heterozygous family members.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 449973     DOI: 10.1056/NEJM197907263010401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  How are you feeling?: A personalized methodology for predicting mental states from temporally observable physical and behavioral information.

Authors:  Suppawong Tuarob; Conrad S Tucker; Soundar Kumara; C Lee Giles; Aaron L Pincus; David E Conroy; Nilam Ram
Journal:  J Biomed Inform       Date:  2017-02-15       Impact factor: 6.317

3.  DNA polymorphism related to the idiopathic hemochromatosis gene: evidence in a recombinant family.

Authors:  V David; P Paul; M Simon; J Y Le Gall; R Fauchet; I Gicquel; I Dugast; L Le Mignon; J Yaouanq; D Cohen
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

4.  Combined segregation and linkage analysis of genetic hemochromatosis using affection status, serum iron, and HLA.

Authors:  I B Borecki; G M Lathrop; G E Bonney; J Yaouanq; D C Rao
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

5.  HLA as a marker of the hemochromatosis gene in Sweden.

Authors:  B Ritter; J Säfwenberg; K S Olsson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 6.  Clinical pharmacokinetics of iron preparations.

Authors:  E Harju
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

7.  Iron and haemochromatosis.

Authors:  M Worwood
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

8.  The use of association data to identify family members at high risk for marker-linked diseases.

Authors:  W J Conte; J I Rotter
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

9.  Association of HLA-linked hemochromatosis with idiopathic refractory sideroblastic anemia.

Authors:  G E Cartwright; C Q Edwards; M H Skolnick; D B Amos
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

10.  Mapping the locus for hereditary hemochromatosis: localization between HLA-B and HLA-A.

Authors:  C Q Edwards; L M Griffen; M M Dadone; M H Skolnick; J P Kushner
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.